Clinical trial
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in…
NCT00318903 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00318903 |
|---|---|
| Title | Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer |
| Official title | A Phase II Study of Irinotecan and Taxotere With Concurrent Radiotherapy as a Preoperative Treatment in Resectable Esophageal Cancer |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Aventis Pharmaceuticals Industry Pharmacia and Upjohn |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Cancer of the Esophagus, Esophagus Cancer, Esophageal Neoplasm, Cancer of Esophagus |
| Intervention type | Drug, Procedure |
| Interventions | Irinotecan (drug), Taxotere (drug), Radiotherapy (procedure), Esophagectomy (procedure) |
| Enrollment | 25 |
| Start date | Jan 1, 2002 |
| Completion | Apr 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | May 25, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: